At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub
FDA Law Blog
JULY 17, 2024
Importantly, the Hub is intended to establish a new model within FDA, which leverages cross-Agency expertise in providing guidance and conducting reviews for products for rare disease populations. those reviewed by the CDER Division of Rare Diseases and Medical Genetics).
105 
Let's personalize your content